NICE recommends ‘breakthrough’ therapy for blood cancer Belantamab mafodotin combination therapy is a second-line treatment option for multiple myeloma that could benefit around 1,500 people.…
NICE recommends mirikizumab as a treatment option for Crohn’s disease Mirikizumab (Omvoh; Eli Lilly), which is already licensed to treat ulcerative colitis but at a lower dose, is now recommended for the treatment of moderately to severely active Crohn's disease.…
Chronic heart failure deaths could fall by 3,000 per year following updated guidance, says NICE The National Institute for Health and Care Excellence said that drugs are being introduced earlier in patient treatment for chronic heart failure, which has been reflected in its draft guidance.…
Walk-in flu vaccine finder for community pharmacy to be launched for 2025/2026 flu season NHS England said the “flu walk-in finder” was developed in response to patient feedback that complained of restrictions to the national booking service and a lack of information on clinic times.…
Long-term plan for NHS workforce must follow 2026 Senedd elections, says RPS The Welsh NHS Confederation and Wellbeing Alliance, which is supported by the Royal Pharmaceutical Society, has urged the Welsh government to develop a workforce plan that expands training places and improves access to professional qualifications.…
Urgent reform needed to fulfil Pharmacy First potential, say pharmacy and GP leaders Exclusive: A joint letter from local pharmaceutical committees and local medical committees in London has called on the government to improve patient access to Pharmacy First.…
Why I set up a pharmacist-led one-stop diabetes clinic in my GP practice How the introduction of a pharmacist-led diabetes clinic has helped to free up GP time and reduce overall hospital admissions, while educating patients on essential care processes.…
Submissions to RPS credentialing scheme rise by 190% in a year The Royal Pharmaceutical Society has reported that there were more than 200 submissions to its credentialing scheme in 2024.…
Pharmacy First passes 5 million consultations landmark Data also show that in the first 13 months of the service, acute sore throat was the most common condition that patients sought help for, with more than 800,000 Pharmacy First consultations.…
NHS pharmacogenomics trial expands to 20 sites across England The PROGRESS trial is planned to finish in early 2026, with an impact assessment produced in the fourth quarter of 2025/2026.…
